HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DuPont Sees Immune Health Probiotic Sales Opening Window On More Microbial Use In Nutrition

Executive Summary

While stockpiling for immune health support drove early sales growth in response to the pandemic, probiotic sales likely will continue increasing, says DuPont Nutrition probiotic marketing head Vanessa Bailey. “My gut tells me I think we could see some sustained increase. There’s going to be some difference in how we behave.”

You may also be interested in...



While Opening Dietary Ingredient Portfolio Wider, DuPont Opens Door On Online Supply Store

In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”

Pandemic Driving Stress In Consumers? DuPont Has A Probiotic Strain For That

HOWARU Calm contains probiotic strain Lpc-37 (L. paracasei) and can be added to supplements or formulated into new products, says DuPont Nutrition & Biosciences. It reports that 65% of adults worldwide are experiencing some daily stress.

On VMS Product Delivery Format, CRN Survey Shows US Consumers Prioritize Ease Of Swallowing

Trade group recently published survey results also show although the total of US consumers using supplements in 2020, 73%, is down 4 percentage points from 2019, a substantial segment of users are taking more products.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel